Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000348997

Medchemexpress LLC Rezvilutamide | 1572045-62-5 | 99.8% | 479.47 | 100 MG
SDP

Supplier:  Medchemexpress LLC HY137448100MG

Encompass_Preferred

Rezvilutamide (SHR3680) is an orally active androgen receptor antagonist used for the study of prostate cancer. It inhibits the nuclear translocation, transcriptional activity, overexpression, and secretion of prostate-specific antigen of the androgen receptor, and induces CYP3A4 and CYP2B6.

  • Orally active androgen receptor antagonist
  • Used for the study of prostate cancer
  • Inhibits nuclear translocation of androgen receptor
  • Inhibits transcriptional activity of androgen receptor
  • Inhibits overexpression and secretion of prostate-specific antigen
  • Induces CYP3A4 and CYP2B6

Catalog No. 50-003-48997


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.